YiChang HEC ChangJiang Pharmaceutical Co., Ltd.

HKEX:1558.HK

8.29 (HKD) • At close September 20, 2024
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) HKD.

2023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22017 Q42017 Q22016 Q42016 Q22015 Q42015 Q22014 Q42014 Q22013 Q4
Omzet 3,085.5833,209.0022,451.6441,293.308711.542202.246264.4082,083.7053,152.7653,071.2591,028.0481,482.428939.314662.253385.875555.629310.046382.864198.597242.307110.226
Kosten van de omzet 663.756645.065566.227332.651328.631101.4581.317352.864471.383450.439159.814238.995158.774121.64277.917136.31779.33898.99648.70571.12429.957
Brutowinst 2,421.8272,563.9371,885.417960.657382.911100.788263.0911,730.8412,681.3822,620.82868.2341,243.433780.54540.611307.958419.312230.708283.868149.892171.18380.269
Brutowinstmarge 0.7850.7990.7690.7430.5380.4980.9950.8310.850.8530.8450.8390.8310.8160.7980.7550.7440.7410.7550.7060.728
Onderzoek- en ontwikkelingskosten 94.02398.26488.70840.90686.98749.66664.44554.983108.87653.743116.575107.52872.87524.0438.37825.85831.11821.18532.70840.8760
Algemene en administratieve kosten 213.595172.107188.78149.672173.278185.124157.746160.322301.364202.049209.895174.49135.61157.37475.57257.13968.40449.83548.16759.69327.578
Verkoop- en marketingkosten 791.646755.504683.485533.105262.738258.929467.022686.8621,243.8461,117.203320.891332.759254.129117.96170.769110.11836.49340.79441.75818.35715.029
Verkoop-, algemene en administratieve kosten 1,012.144927.335873.613677.434419.772463.473625.548842.0131,556.9351,312.261530.786507.249389.74175.335146.341167.257106.82990.62992.37778.0542.607
Overige kosten 000000000000000000-3.407-8.382-8.382
Bedrijfskosten 1,494.071,199.9451,668.525863.22340.613577.80996.995863.9081,493.9691,370.715521.734500.792403.284180.12124.319150.75690.93886.20577.70659.22534.225
Bedrijfsresultaat 1,305.7161,484.45479.605243.11637.008-495.114-75.768909.4621,229.6051,299.91340.794742.641401.989360.491151.01268.556131.756197.66372.191111.95851.361
Bedrijfsresultaat ratio 0.4230.4630.0320.1880.052-2.448-0.2870.4360.390.4230.3310.5010.4280.5440.3910.4830.4250.5160.3640.4620.466
Totaal overige inkomsten en kosten netto -440.798-222.601-3.781-279.518-115.988-93.09328.366-151.626-133.186-127.27614.6674.222-12.027-2.25837.612-4.112-0.204-14.509-6.534-14.5-10.583
Inkomen voor belasting 864.9181,261.85375.824-36.402-78.98-588.204252.598757.8361,096.4191,172.634355.461746.863389.962358.233188.622264.444131.552183.15465.65797.45840.779
Inkomen voor belasting ratio 0.280.3930.031-0.028-0.111-2.9080.9550.3640.3480.3820.3460.5040.4150.5410.4890.4760.4240.4780.3310.4020.37
Belastingkosten 33.016237.9295.8773.941.76781.22731.928141.095149.404212.46465.034136.07258.87762.96123.0149.45919.0529.90612.37115.4016.943
Nettowinst 963.1291,029.495109.401-32.798-80.621-507.028221.947617.508950.285968.424307.992634.544345.241301.86165.612214.985112.502153.24853.28682.05733.836
Nettowinstmarge 0.3120.3210.045-0.025-0.113-2.5070.8390.2960.3010.3150.30.4280.3680.4560.4290.3870.3630.40.2680.3390.307
WPA (Winst Per Aandeel) 1.091.170.12-0.04-0.092-0.580.0960.630.991.090.340.70.380.330.180.240.160.250.0790.0910.038
Verwaterde WPA 1.091.170.12-0.037-0.092-0.580.20.560.841.090.340.70.380.330.180.240.160.250.0790.0910.038
EBITDA 1,499.411,673.063274.302417.181173.372-379.926-8.581958.8161,268.1781,343.17374.593769.93428.955377.32165.245281.77144.707210.45987.125128.96959.348
EBITDA ratio 0.4860.5210.1120.3230.244-1.879-0.0320.460.4020.4370.3640.5190.4570.570.4280.5070.4670.550.4390.5320.538